These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 29702023)
41. ¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization. Koo PJ; David Crawford E Oncology (Williston Park); 2014 Dec; 28(12):1057-62, 1064-5. PubMed ID: 25738199 [TBL] [Abstract][Full Text] [Related]
42. Therapy-induced bone changes in oncology imaging with Ahmed N; Sadeq A; Marafi F; Gnanasegaran G; Usmani S Ann Nucl Med; 2022 Apr; 36(4):329-339. PubMed ID: 35218508 [No Abstract] [Full Text] [Related]
43. Unsuspected Metastases to Muscles in Osteosarcoma Detected on 18F-Sodium Fluoride PET-CT. Usmani S; Marafi F; Rasheed R; Bakiratharajan D; Al Maraghy M; Al Kandari F Clin Nucl Med; 2018 Sep; 43(9):e343-e345. PubMed ID: 30080191 [TBL] [Abstract][Full Text] [Related]
44. Lesion detection in 18F-sodium fluoride bone imaging: a comparison of attenuation-corrected versus nonattenuation-corrected PET reconstructions from modern PET-CT systems. Bebbington NA; Zacho HD; Holdgaard PC Nucl Med Commun; 2022 Jan; 43(1):78-85. PubMed ID: 34887371 [TBL] [Abstract][Full Text] [Related]
45. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. Hetzel M; Arslandemir C; König HH; Buck AK; Nüssle K; Glatting G; Gabelmann A; Hetzel J; Hombach V; Schirrmeister H J Bone Miner Res; 2003 Dec; 18(12):2206-14. PubMed ID: 14672356 [TBL] [Abstract][Full Text] [Related]
46. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma. Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187 [TBL] [Abstract][Full Text] [Related]
47. Burden of metastatic bone disease measured on 18F-NaF PET/computed tomography studies as a prognostic indicator in patients with medullary thyroid cancer. Ueda CE; Duarte PS; de Castroneves LA; Flávio J; Marin G; Sado HN; Sapienza MT; Hoff AO; Buchpiguel CA Nucl Med Commun; 2020 May; 41(5):469-476. PubMed ID: 32187160 [TBL] [Abstract][Full Text] [Related]
48. Validation of the Semiautomatic Quantification of Brito AE; Mourato F; Santos A; Mosci C; Ramos C; Etchebehere E J Nucl Med Technol; 2018 Dec; 46(4):378-383. PubMed ID: 30076246 [TBL] [Abstract][Full Text] [Related]
49. Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT. Dyrberg E; Larsen EL; Hendel HW; Thomsen HS Acta Radiol; 2018 Sep; 59(9):1119-1125. PubMed ID: 29313360 [TBL] [Abstract][Full Text] [Related]
50. Superiority of NaF PET/CT Over Chest CT in a Case of Osteosarcoma. Morland D; Godard F; Lalire P; Eymard JC; Papathanassiou D Clin Nucl Med; 2021 Jul; 46(7):584-585. PubMed ID: 33782283 [TBL] [Abstract][Full Text] [Related]
51. Rare Thyroid Cartilage Metastasis From Breast Cancer Visualized on 18F-NaF PET/CT. Usmani S; Ahmed N; Ilyas MW; Murad S; Al Kandari F Clin Nucl Med; 2021 Jan; 46(1):43-44. PubMed ID: 33156044 [TBL] [Abstract][Full Text] [Related]
52. Unusual Finding of a Tumor Thrombus Arising From Osteosarcoma Detected on 18F-NaF PET/CT. Verma P; Purandare N; Agrawal A; Shah S; Rangarajan V Clin Nucl Med; 2016 Jun; 41(6):e304-6. PubMed ID: 26909709 [TBL] [Abstract][Full Text] [Related]
54. 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound. Avery R; Kuo PH Clin Nucl Med; 2013 Sep; 38(9):746-8. PubMed ID: 23797230 [TBL] [Abstract][Full Text] [Related]
55. Novel Musculoskeletal and Orthopedic Applications of Raynor WY; Borja AJ; Hancin EC; Werner TJ; Alavi A; Revheim ME PET Clin; 2021 Apr; 16(2):295-311. PubMed ID: 33589389 [TBL] [Abstract][Full Text] [Related]
56. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330 [TBL] [Abstract][Full Text] [Related]
57. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT]. Moragas M; Soler M; Riera E; García JR Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280 [TBL] [Abstract][Full Text] [Related]
58. Efficacy of Yellanki DP; Kothekar E; Al-Zaghal A; Cheng N; Werner TJ; Høilund-Carlsen PF; Alavi A Hell J Nucl Med; 2018; 21(3):181-185. PubMed ID: 30411728 [TBL] [Abstract][Full Text] [Related]
59. A statistically optimized regional thresholding method (SORT) for bone lesion detection in Perk T; Chen S; Harmon S; Lin C; Bradshaw T; Perlman S; Liu G; Jeraj R Phys Med Biol; 2018 Nov; 63(22):225018. PubMed ID: 30457117 [TBL] [Abstract][Full Text] [Related]
60. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. Grant FD; Fahey FH; Packard AB; Davis RT; Alavi A; Treves ST J Nucl Med; 2008 Jan; 49(1):68-78. PubMed ID: 18077529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]